Reza Bayat Mokhtari | Molecular Biology | Editorial Board Member

Published on by Medical Lab Scientist

Dr. Reza Bayat Mokhtari | Molecular Biology | Editorial Board Member

Director | Association of Clinical Immunology and Cancer Research | United States

Dr. Reza Bayat Mokhtari is a research-intensive biomedical scientist recognized for significant contributions to oncology and translational medicine, with a documented impact of 4,475 citations, an h-index of 20, and an i10-index of 30. The research portfolio focuses on molecular mechanisms of cancer progression, tumor microenvironment dynamics, and resistance to therapy, particularly in lung, breast, pancreatic, hepatic, and neuroendocrine malignancies. Core scientific contributions include studies on Hippo–YAP/TAZ signaling, Agrin-driven oncogenic processes, cancer stem cell regulation, hypoxia-associated pathways, and rational combination and repurposing strategies to improve immunotherapy outcomes. This body of peer-reviewed work bridges fundamental cancer biology with clinically relevant translational models, supporting biomarker development and precision oncology approaches. Overall, the scholarly output reflects sustained productivity, interdisciplinary scope, and measurable influence within the cancer research community.

Citation Metrics (Google Scholar)

6000

4500

3000

1500

0

 

4475
Citations

20
h-index

30
i10-index

Citations

h-index

i10-index

Featured Publications

Wenhe Lin | Genetics | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Wenhe Lin | Genetics | Best Researcher Award

Wenhe Lin | University of Chicago | United States

Dr. Wenhe Lin is a researcher affiliated with the Department of Human Genetics at The University of Chicago, United States, whose scientific work focuses on uncovering the genetic and molecular mechanisms that regulate physiological responses to diet and environmental factors. His research contributes to a deeper understanding of how gene expression adapts to metabolic stress, offering insights into the biological foundations of complex diseases. Dr. Lin has published one peer-reviewed article titled “Genetic regulatory effects in response to a high-cholesterol, high-fat diet in baboons,” which appeared in Cell Genomics. This study highlights the interplay between nutrition and genetic regulation, addressing critical questions in metabolic and nutritional genomics. According to his Scopus author profile, Dr. Lin has authored 1 scientific document, which has received 10 citations, and maintains an h-index of 1, reflecting the early yet impactful nature of his academic contributions. His research approach integrates genomic sequencing, bioinformatics, and systems biology to explore gene–environment interactions that influence disease susceptibility. At The University of Chicago, he continues to advance research in human genetics with an emphasis on precision health and individualized nutrition strategies. Dr. Lin’s emerging body of work demonstrates strong potential to shape future investigations into metabolic regulation, genetic variability, and their implications for personalized medicine and human health.

Profiles: ORCID | Scopus | Google Scholar

Featured Publications

Ding Wen Wu | Transfusion Medicine | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Ding Wen Wu | Transfusion Medicine | Best Researcher Award

Professor | NYU Grossman School of Medicine | United states 

Prof. Ding Wen Wu is a distinguished researcher and educator in the field of transfusion medicine, currently affiliated with the NYU Grossman School of Medicine, United States. With a career dedicated to advancing patient blood management and diagnostic innovation, he has made notable contributions that bridge laboratory research and real-world clinical practice. His research focuses on improving transfusion safety, optimizing resource utilization, and promoting evidence-based approaches that enhance healthcare efficiency and patient outcomes. Prof. Wu’s academic profile demonstrates strong scholarly impact, with 10 published scientific documents, 97 citations, and an h-index of 3, reflecting the quality and growing influence of his work within the international medical community. His studies have appeared in highly respected journals such as JAMA Internal Medicine, Life, Healthcare, and the Journal of Clinical Apheresis, where his findings have shaped new perspectives in transfusion medicine and clinical diagnostics. Beyond research, Prof. Wu is also recognized for his mentorship and leadership in education, actively guiding emerging medical scientists and fostering collaboration, innovation, and integrity in research. His interdisciplinary approach and commitment to continuous improvement underscore his vision for integrating artificial intelligence, real-world data analytics, and precision-based methodologies into modern healthcare systems. Through his dedication to advancing transfusion science and promoting global standards in laboratory medicine, Prof. Ding Wen Wu continues to serve as an inspiring figure whose work contributes significantly to safer, more efficient, and patient-centered medical practices worldwide.

Profiles: Scopus | ORCID

Feaured Publications

Liying Ren | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Liying Ren | Molecular Biology | Best Researcher Award

Liying Ren | Peking University |China

Ren Liying is a medical researcher in hepatology and oncology, currently pursuing her Ph.D. in Internal Medicine at the Peking University Hepatology Institute, Peking University People’s Hospital, under the mentorship of Professor Chen Hongsong. She earned her Bachelor’s degree in Clinical Medicine from Hubei University of Science and Technology and her Master’s degree from Guilin Medical University under Professor Liao Weijia, before advancing to doctoral studies. Her research focuses on hepatocellular carcinoma (HCC), with an emphasis on integrating molecular biology, imaging, and clinical practice to improve patient outcomes. Ren has authored and co-authored several impactful publications in respected journals, including Cancers, Journal of Hepatocellular Carcinoma, BMC Cancer, World Journal of Gastroenterology, and Cancer Medicine. As first author, her study in Cancers identified the tumor-suppressive role of hemopexin in HCC via TNF-α–mediated mitochondrial apoptosis, while her review explored radiomics and radiogenomics as tools to bridge imaging and molecular characterization in liver cancer. She has also contributed to predictive models and radiomics-based approaches for recurrence and prognosis stratification after surgical resection of HCC. With a strong clinical foundation and commitment to translational research, Ren represents a new generation of physician-scientists advancing precision medicine in liver disease and cancer.

profile: Google scholar

Featured Publications